These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 3335031

  • 1. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
    Shapiro WR, Voorhies RM, Hiesiger EM, Sher PB, Basler GA, Lipschutz LE.
    Cancer Res; 1988 Feb 01; 48(3):694-701. PubMed ID: 3335031
    [Abstract] [Full Text] [Related]

  • 2. Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow.
    Hiesiger EM, Voorhies RM, Basler GA, Lipschutz LE, Posner JB, Shapiro WR.
    Ann Neurol; 1986 Jan 01; 19(1):50-9. PubMed ID: 3080944
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intracarotid infusion of hypertonic mannitol changes permeability of blood-brain barrier to methotrexate in rats.
    Pan GY, Liu XD, Liu GQ.
    Acta Pharmacol Sin; 2000 Jul 01; 21(7):613-6. PubMed ID: 11360668
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of hyperosmotic blood-brain barrier disruption on blood-to-tissue transport in ENU-induced gliomas.
    Warnke PC, Blasberg RG, Groothuis DR.
    Ann Neurol; 1987 Sep 01; 22(3):300-5. PubMed ID: 3118762
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [ACNU delivery to malignant glioma tissue by osmotic blood brain barrier modification with intracarotid infusion of hyperosmoral mannitol].
    Miyagami M, Kagawa Y, Tsubokawa T.
    No Shinkei Geka; 1985 Sep 01; 13(9):955-63. PubMed ID: 2999632
    [Abstract] [Full Text] [Related]

  • 10. Blood-brain barrier disruption and methotrexate in the treatment of a readily transplantable intracerebral osteogenic sarcoma of rats.
    Cosolo W, Christophidis N.
    Cancer Res; 1987 Dec 01; 47(23):6225-8. PubMed ID: 3119195
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH, Chen YF, Chen FD, Hwang JJ, Chen JC, Liu RS, Kai JJ, Chang CW, Wang HE.
    J Nucl Med; 2005 Nov 01; 46(11):1858-65. PubMed ID: 16269600
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. "Facilitated" amino acid transport is upregulated in brain tumors.
    Miyagawa T, Oku T, Uehara H, Desai R, Beattie B, Tjuvajev J, Blasberg R.
    J Cereb Blood Flow Metab; 1998 May 01; 18(5):500-9. PubMed ID: 9591842
    [Abstract] [Full Text] [Related]

  • 15. Increased blood-brain permeability with hyperosmolar mannitol increases cerebral O2 consumption and O2 supply/consumption heterogeneity.
    Chi OZ, Wei HM, Lu X, Weiss HR.
    J Cereb Blood Flow Metab; 1996 Mar 01; 16(2):327-33. PubMed ID: 8594066
    [Abstract] [Full Text] [Related]

  • 16. [3H]Methotrexate loss from the rat brain following enhanced uptake by osmotic opening of the blood-brain barrier.
    Ohata M, Fredericks WR, Neuwelt EA, Sundaram U, Rapoport SI.
    Cancer Res; 1985 Mar 01; 45(3):1092-6. PubMed ID: 3971363
    [Abstract] [Full Text] [Related]

  • 17. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF, Yang W, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH, Soloway AH.
    Cancer Res; 1997 Mar 15; 57(6):1129-36. PubMed ID: 9067283
    [Abstract] [Full Text] [Related]

  • 18. The effect of an amino acid-lowering diet on the rate of melphalan entry into brain and xenotransplanted glioma.
    Groothuis DR, Lippitz BE, Fekete I, Schlageter KE, Molnar P, Colvin OM, Roe CR, Bigner DD, Friedman HS.
    Cancer Res; 1992 Oct 15; 52(20):5590-6. PubMed ID: 1394182
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries.
    Erdlenbruch B, Alipour M, Fricker G, Miller DS, Kugler W, Eibl H, Lakomek M.
    Br J Pharmacol; 2003 Dec 15; 140(7):1201-10. PubMed ID: 14597599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.